Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune ...

Increasing aging populations and growing hospital infrastructures will drive demand for rheumatoid arthritis drugs.Wilmington ...

Rheumatoid arthritis brings along joint pain and fatigue that can impact various aspects of your life. While it can come come in the way of household chores, daily activities, it can also get ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune cells attacking the joints and can result in pain, swelling, and damage to ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Predictors of MTX monotherapy treatment success among patients with RA include low disease activity, normal body weight and ESR levels, and fewer tender joints.

Two "key" genes have been identified by scientists linking the painful condition and the bone disease osteoporosis.

Attorney General Keith Ellison celebrates settlements with two drug companies he accused of “scheming” to raise prices on ...

The National Institutes of Health has awarded a five-year, $2.79 million grant to Shuying Yang and Michael Mitchell for their ...

This treatment effect lessened during the 1-year follow-up ... “If you look at all the people who get rheumatoid arthritis, there’s probably no way those could have the same exact pathways,” he said. ...

New research shows that blood-based immunophenotyping can enhance rheumatoid arthritis treatment by identifying immune ...